Extended Reality (XR) in the Digital Fashion Landscape

Venlafaxine extended release (XR) in the treatment of panic disorder

Panic disorder is a chronic, recurrent illness, with a lifetime prevalence of about 5%. It is associated with substantial functional impairment, and studies suggest that treatment with medication alone (and no instruction in exposure to feared and avoided situations) is less than optimal. In fact, 40%-90% of patients in long-term follow-up studies in the late 1980s and early 1990s, treated with...

The Role of Digital Reality Technologies in Libraries: A Systemic Review

Introduction: Fourth-generation libraries can no longer be satisfied with web software facilities and must use technologies, including digital realities to increase the level of service and attract clients. Therefore, this review aimed to identify the roles and effects of these technologies in libraries. Methods: In this systematic review, PubMed, Web of Science, Scopus, and Google Scholar adv...

Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX)

OBJECTIVES Once-monthly intramuscular extended-release naltrexone (XR-NTX) has demonstrated efficacy for the prevention of relapse in opioid dependence, providing an alternative to agonist or partial agonist maintenance (ie, methadone and buprenorphine). The question remains, for whom is this unique treatment most efficacious and can patient-treatment matching factors be identified? METHODS A...

Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures

INTRODUCTION Saxagliptin added to metformin extended release (XR) and uptitrated metformin XR were evaluated for their impact on daily glucose measurements and their tolerability in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin monotherapy. METHODS Patients aged 18-78 years on metformin 850-1,500 mg with glycated hemoglobin (HbA1c) 7.5-11.5% at screening...

The Digital Landscape for Children